Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02953613 · ClinicalTrials.gov registry record
LipiScan- Ultrasound INterrogation of Atherosclerotic Coronary Arteries:
A clinical trial, sponsored by Corewell Health East.
- Terminated
- Registry status
- 7
- Enrollment target
NCT02953613: Clinical Trial study, sponsored by Corewell Health East.
NCT02953613 is a clinical trial that was terminated before completion, run by Corewell Health East. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02953613 was terminated before completion, sponsored by Corewell Health East.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
The goal of this study is to correlate both plaque and % lipid core content assessed by NIRS-IVUS (Imaging technique) to plaque burden and % lipid core content in coronary computerized tomographic angiography (CCTA) completed at 1 week in non-culprit coronary arteries.
Primary Outcome
To correlate both plaque burden and % lipid core content assessed by NIRS-IVUS to plaque burden and % lipid core content on coronary computerized tomographic angiography (CCTA) completed at 1 week in non-culprit coronary arteries.
Interventions
- DEVICE NIRS/IVUS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2016-04-28 |
| Est. Completion | 2017-11-20 |
Why NCT02953613 stopped before completion
NCT02953613 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which NIRS/IVUS is the first listed.
NCT02953613 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02953613 about?
NCT02953613 is a clinical study titled "LipiScan- Ultrasound INterrogation of Atherosclerotic Coronary Arteries:". The goal of this study is to correlate both plaque and % lipid core content assessed by NIRS-IVUS (Imaging technique) to plaque burden and % lipid core content in coronary computerized tomographic angiography (CCTA) completed at 1 week in non-culprit coronary arteries.
What is the current status of trial NCT02953613?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2016-04-28. Estimated completion is 2017-11-20.
What interventions are being tested in trial NCT02953613?
The interventions under investigation include: NIRS/IVUS (DEVICE).
Who is sponsoring clinical trial NCT02953613?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI